Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page was updated to Revision: v3.5.4, representing an internal update to the page's revision history. It does not modify any study details, endpoints, or inclusion criteria visible to users.SummaryDifference0.0%

- Check22 days agoChange DetectedThe Taiwan site listing was updated from 'Taoyuan, Taiwan, 333' to 'Taoyuan City, Taiwan, 333' to clarify the precise city designation. This clarifies the recruitment location for that site within the study's geographic footprint.SummaryDifference0.0%

- Check29 days agoChange DetectedThe page footer's Revision tag has been updated from v3.5.2 to v3.5.3, representing a new build of the page without changes to the underlying study details.SummaryDifference0.0%

- Check36 days agoChange DetectedUpdated study record dates/status entries (e.g., listing newer posted/last update timestamps and a withdrawn indicator). Removed an earlier named investigator/contact and associated role/contact/location status information.SummaryDifference0.1%

- Check43 days agoChange Detected- The page metadata now shows Revision: v3.5.2; the previous label v3.5.0 has been removed.SummaryDifference0.0%

- Check50 days agoChange DetectedPadova, Italy, 35128 was added and Padua, Italy, 35128 was removed from the study locations.SummaryDifference0.0%

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.